Unichem Laboratories Ltd. — Major Shareholding Notification 2023

Sep 21, 2023

BY E-MAIL

September 21, 2023

BSE Ltd.	The National Stock Exchange ofIndia Ltd.
Phiroze Jeejeebhoy Towers	Exchange Plaza, 5th Fir, Plot # C/1
27lh Floor, Dalai Street	G Block, Bandra-Kurla Complex,
Mumbai 400 023	Bandra (E), Mumbai 400 051.
E-mail: corp.relations@bseindia.com	E-mail : takeover@nse.co.in

Dear Sir,

Re: Declaration under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201 1, we are enclosing herewith our disclosure for acquisition of 1,35,79,571 equity shares of Rs. 2/- each representing 19.29% of the paid-up equity share capital of Unichem Laboratories Ltd. (506690 on BSE; UNICHEMLAB on NSE) through open offer.

Kindly acknowledge the receipt.

Thanking you

Yours faithfully For and on behalf Ipca Laboratories Limited

Harish P. Kamath Company Secretary

Enel: a/a

Unichem Laboratories Limited Unichem Bhavan Prabhat Estate, Off S.V. Road, Jogeshwari (West), Mumbai - ^{400 102} E-mail id : pradeep.bhandari@unichemlabs.com shares@unichemlabs.com Cc:

Ipca Laboratories Ltd.

www.ipca.com 125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T: +91 22 6210 5000 F: +91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name ofthe Target Company (TC)	Unichem Laboratories Limited (506690 on BSE; UNICHEMLAB on NSE)
Name(s) ofthe acquirer and Persons Acting in Concert (PAC) with the Acquirer	Ipca Laboratories Limited
Whether the acquirer belongs to Promoter / Promoter Group	Yes. Acquirer belongs to Promoter / Promoter Group
Name(s) ofthe Stock Exchange(s) where the shares ofTC are listed	BSE Ltd. (BSE); and The National Stock Exchange ofIndia Ltd. (NSE)
Details ofthe acquisition as follows	Number	% w.r.t total share / voting capital wherever applicable (*)	% w.r.t. total diluted share / voting capital of the TC (**)
Before the acquisition under consideration, holding of acquirer along with FACs of:
Shares carrying voting rights a.	2,35,01,440	33.38%	33.38%
in the nature of Shares encumberance b. (pledge/Iien/non-disposal undertaking/others)	Nil	Nil	Nil
Voting rights (VR) otherwise than by c. equity shares	Nil	Nil	Nil
Warrants / convertible securities/ d. any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category)	Nil	Nil	Nil
Total (a+b+c+d) e.	2,35,01,440	33.38%	33.38%

Ipca Laboratories Ltd.

www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837

	Details ofthe acquisition as follows	Number	% w.r.t total share / voting capital wherever applicable (*)	% w.r.t. total diluted share / voting capital ofthe TC (**)
	Details of Acquisition / Sale
a.	Shares carrying voting rights acquired	1,35,79,571	19.29%	19.29%
b.	VRs acquired otherwise than by equity shares	Nil	Nil	Nil
c.	Warrants / Convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired	Nil	Nil	Nil
d.	Shares in the nature ofencumberance (pledge/lien/non-disposal undertaking/others)	Nil	Nil	Nil
e.	Total (a+b+c+/-d)	1,35,79,571	19.29%	19.29%
	After the acquisition, holding of
a.	Shares carrying voting rights	3,70,81,011	52.67%	52.67%
b.	VRs otherwise than by equity shares	Nil	Nil	Nil
c.	Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition	Nil	Nil	Nil
d.	in the nature of Shares encumberance (pledge/lien/non-disposal undertaking/others)	Nil	Nil	Nil
e.	Total (a+b+c+d)	3,70,81,011	52.67%	52.67%
	Mode of acquisition (eg. Open market/ public issue/rights issue/preferential allotment/inter se transfer etc.)	Acquired pursuant to open offer made under SEBI (SAST) Regulations
	Date of acquisition ofshares or date ofreceipt ofintimation of allotment of shares/VR/warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC	21st September, 2023

^I pea Laboratories Ltd.

www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| I: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837

Details ofthe acquisition as follows	Number	% w.r.t total share/ voting capital wherever applicable (*)	% w.r.t. total diluted share / voting capital of the TC (**)
Equity share capital/total voting capital ofthe TC before the said acquisition	7,04,05,750 equity shares of Rs. 2/- each amounting to Rs. 14,08,11,500/-	100%	100%
Equity share capital /total voting capital ofthe TC after the said acquisition	7,04,05,750 equity shares of Rs. 2/- each amounting to Rs. 14,08,11,500/-	100%	100%
Total diluted share/voting capital ofthe TC after the said acquisition (considering balance outstanding convertible warrants)	7,04,05,750 equity shares of Rs. 2/- each amounting to Rs. 14,08,11,500/-	100%	100%

Signature ofthe acquirer / Authorised Signatory:

For Ipca Laboratories Ltd.

Harish P. Kamath Company Secretary

Place: Mumbai

Date: 21s' September, 2023

Ipca Laboratories Ltd.

www.ipca.com

125, KandivlilndustrialEstate,CTSNo. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India ^| T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837